nei THIS MONTH IN
PSYCHOPHARMACOLOGY
2018 NEI Congress Young Investigator Poster Competition Winners
November 10, 2018   

The 2018 NEI Congress Scientific Poster Session and Reception was held on Friday, November 9 and featured nearly 100 posters covering the full spectrum of mental health research and clinical data. Among them, three particularly stood out for the quality of their data and contributions to the field. Presented below are the winners of the 2018 NEI Congress Young Investigator Poster Competition.
 Continue reading
Keeping up With the Clinical Advances: Depression
November 9, 2018   

At the 2018 NEI Congress, Dr. Stephen Stahl provided an update on novel antidepressant treatments that are recently available or in development, including the mechanisms of action that are thought to underlie their potential antidepressant effects...
 Continue reading
Keeping up With the Clinical Advances: Schizophrenia
November 8, 2018   

At the 2018 NEI Congress, Dr. Jonathan Meyer discussed novel agents in development or recently FDA approved that may aid in many of these challenges...
 Continue reading
No Benefit of Minocycline for Negative Symptoms of Schizophrenia
November 2, 2018   

Emerging evidence of inflammatory processes serving as underlying mechanisms in depression, and schizophrenia has strengthened interest in minocycline and other anti-inflammatory drugs as a new avenue for psychiatric treatment. In a recent double-blind, placebo-controlled, randomized controlled trial...
 Continue reading (Members only)
fMRI Data Suggest Possible Biomarker for Conversion to Psychotic Disorder
October 22, 2018   

In a recent study, multi-paradigm functional magnetic resonance imaging (fMRI) data from the North American Prodrome Longitudinal Study consortium was analyzed to examine differences in brain connectivity in patients who converted to schizophrenia versus those who did not. ...
 Continue reading (Members only)
The HPA Axis and Peripartum Depression
October 16, 2018   

Many dramatic physiological changes happen during and after pregnancy that may cause the upsurge in risk of psychiatric disorders that occurs during the perinatal period. ...
 Continue reading (Members only)
Veterans Administration Releases Suicide Report
October 12, 2018   

With the newly released VA National Suicide Data report, the US Department of Veterans Affairs provides data as to the demographics and suicide rates among Veterans and non-Veteran adults spanning from 2005 to 2016 and...
 Continue reading (Members only)
Two New Medications Approved for Migraine Prevention
October 9, 2018   

The US Food and Drug Administration (FDA) has approved two anti-calcitonin gene-related peptide (CGRP) treatments for migraines...
 Continue reading (Members only)
DEA Reschedules the Cannabidiol Drug Epidiolex
October 6, 2018   

Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act...
 Continue reading
TMS for Stimulant Withdrawal?
October 4, 2018   

A recent randomized control study examined whether application of repetitive transcranial magnetic stimulation (rTMS) to the left DLPFC could modulate withdrawal symptoms from methamphetamine...
 Continue reading (Members only)
12345678910...
Top of Page